Ready-to-use AAV1 particles produced from pAAV-S5E2-GFP-fGFP (#135631). In addition to the viral particles, you will also receive purified pAAV-S5E2-GFP-fGFP plasmid DNA. Bicistronic expression of GFP and membrane-targeted GFP under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.

Ready-to-use AAV PHP.eB particles produced from pAAV-S5E2-GFP-fGFP (#135631). In addition to the viral particles, you will also receive purified pAAV-S5E2-GFP-fGFP plasmid DNA. Bicistronic expression of GFP and membrane-targeted GFP under the control of the E2 regulatory element. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

donor plasmid for CRISPR Cas9 knockin near the Aedes aegypti m / M locus

donor plasmid for CRISPR Cas9 knockin near the Aedes aegypti m / M locus

Luminescent reporter system, readthrough control, NMD negative control. No intron in 5'UTR

Glucarate biosensor. High copy plasmid that expresses GFP proportional to glucarate concentration.

Membrane-bound anti-GFP nanobody conjugated to mCherry

GFP with Frt sites for FLP-mediated knock-out of gene function in C. elegans

PiggybacTransposon-based tunable and temporal expression control of SARS-CoV2 N and mCherry

Expresses Mcu-targeted shRNA under control of the U6 promoter and hrGFP under control of the synthetic CAG promoter